In the third quarter of 2024, Adjusted EBITDA excluding stock-based compensation, changes in the fair market value of the Company's warrant liability, and other one-time expenses, was a $ (5.5) ...

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today reported financial results for the quarter ended ...